A European multi-language initiative to make the general population aware of independent clinical research: the European Communication on Research Awareness Need project

Article English OPEN
Mosconi, P. ; Antes, G. ; Barbareschi, G. ; Burls, A. ; Demotes-Mainard, J. ; Chalmers, I. ; Colombo, C. ; Garattini, S. ; Gluud, C. ; Gyte, G. ; Mcllwain, C. ; Penfold, M. ; Post, N. ; Satolli, R. ; Valetto, M. R. ; West, B. ; Wolff, S. (2016)
  • Publisher: Springer Nature
  • Journal: Trials (vol: 17)
  • Related identifiers: pmc: PMC4710012, doi: 10.1186/s13063-015-1146-7
  • Subject: Independent clinical trial | Medicine (miscellaneous) | Patients | Lay people | Health research | Information | Access to information | Research | Pharmacology (medical) | RA

BACKGROUND: The ECRAN (European Communication on Research Awareness Needs) project was initiated in 2012, with support from the European Commission, to improve public knowledge about the importance of independent, multinational, clinical trials in Europe. \ud \ud METHODS: Participants in the ECRAN consortium included clinicians and methodologists directly involved in clinical trials; researchers working in partnership with the public and patients; representatives of patients; and experts in science communication. We searched for, and evaluated, relevant existing materials and developed additional materials and tools, making them freely available under a Creative Commons licence. \ud \ud RESULTS: The principal communication materials developed were: 1. A website ( http://ecranproject.eu ) in six languages, including a Media centre section to help journalists to disseminate information about the ECRAN project 2. An animated film about clinical trials, dubbed in the 23 official languages of the European Community, and an interactive tutorial 3. An inventory of resources, available in 23 languages, searchable by topic, author, and media type 4. Two educational games for young people, developed in six languages 5. Testing Treatments interactive in a dozen languages, including five official European Community languages 6. An interactive tutorial slide presentation testing viewers' knowledge about clinical trials \ud \ud CONCLUSIONS: Over a 2-year project, our multidisciplinary and multinational consortium was able to produce, and make freely available in many languages, new materials to promote public knowledge about the importance of independent and international clinical trials. Sustained funding for the ECRAN information platform could help to promote successful recruitment to independent clinical trials supported through the European Clinical Research Infrastructure Network.
  • References (32)
    32 references, page 1 of 4

    1. ECRIN European Clinical Research Infrastructure Network. http://www.ecrin. org. Accessed 9 January 2016.

    2. European Parliament. Clinical trials: clearer rules, better protection for patients. 2014 www.europarl.europa.eu/news/en/news-room/content/20140331IPR41186/ html/Clinical-trials-clearer-rules-better-protection-for-patients. Accessed 9 January 2016.

    3. Westra AE, Bos W, Cohen AF. Clinical trials regulation. Needs a few tweaks before implementation. BMJ. 2014;348:g3710.

    4. Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001;19(15):3554-61.

    5. Dear RF, Barratt AL, Askie LM, Butow PN, McGeechan K, Crossing S, et al. Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trial. Ann Oncol. 2012;23(7):1912-8.

    6. Fayter D, McDaid C, Eastwood A. A systematic review highlights threats to validity in studies of barriers to cancer trial participation. J Clin Epidemiol. 2007;60(10):990-1001.

    7. Jenkins V, Farewell D, Batt L, Maughan T, Branston L, Langridge C, et al. The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. Br J Cancer. 2010;103(12):1801-7.

    8. O'Connell D, Mosconi P. An active role for patients in clinical research? Drug Dev Res. 2006;67:188-92.

    9. Stewart RJ, Caird J, Oliver K, Oliver S. Patients' and clinicians' research priorities. Health Expect. 2011;14(4):439-48.

    10. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001;358(9295):1772-7.

  • Metrics
    No metrics available
Share - Bookmark